Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
24%
OVERLAP
BY WEIGHT
42
# OF OVERLAPPING
HOLDINGS
BMED
115
HOLDINGS
40%
ALSO IN XBI
XBI
116
HOLDINGS
37%
ALSO IN BMED
SECTOR DRIFT (BMED minus XBI)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BMED |
Weight in XBI |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 3.7% | 2.5% | 2.5% |
|
ABBVIE INC | 3.1% | 2.5% | 2.5% |
|
NEUROCRINE BIOSCIENCES INC | 1.5% | 2.5% | 1.5% |
|
NATERA INC | 1.5% | 2.0% | 1.5% |
|
EXACT SCIENCES CORP | 1.4% | 2.1% | 1.4% |
BMED Overweight Relative to XBI
|
BOSTON SCIENTIFIC CORP | 4.9% |
|
INTUITIVE SURGICAL INC | 4.9% |
 |
ROCHE HOLDING AG-BR | 3.4% |
 |
ARGENX SE ADR | 3.3% |
|
LONZA GROUP AG-REG | 2.7% |
|
ABBOTT LABORATORIES | 2.7% |
 |
MEDTRONIC PLC | 2.3% |
|
UCB SA | 2.2% |
|
BRISTOL-MYERS SQUIBB CO | 2.2% |
|
REPLIGEN CORP | 2.1% |
BMED Underweight Relative to XBI
|
INCYTE CORP | -2.7% |
|
REGENERON PHARMACEUTICALS | -2.6% |
|
BIOMARIN PHARMACEUTICAL INC | -2.5% |
|
MODERNA, INC. | -2.4% |
|
ALNYLAM PHARMACEUTICALS INC | -2.3% |
|
VERTEX PHARMACEUTICALS INC | -2.2% |
|
HALOZYME THERAPEUTICS INC | -2.1% |
|
INSMED INC | -2.0% |
|
MADRIGAL PHARMACEUTICALS, INC. | -1.9% |
|
UNITED THERAPEUTICS CORP | -1.8% |